Leon Rosenberg, MD
Psychiatry · Cherry Hill, NJNPI 1215941000
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $255,142 of the $256,884 with a category attached, or 99.3%. Axsome Therapeutics, Inc. accounts for 97.1% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2024 at $249,612 and has fallen 99.9% since, to $208 in 2025. Among psychiatry clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $1976.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$249K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$4K
- Biogen$2K
- AbbVie$495
- Sunovion Pharmaceuticals Inc.$274
- Otsuka America Pharmaceutical, Inc.$162
- plus $744 from 16 others
Across 614 payments — averaging $10,523 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$1.9M
- Boehringer Ingelheim$1.2M
- Sage Therapeutics, LLC$952K
- Sumitomo Pharma America, Inc.$572K
- Axsome Therapeutics, Inc.$520K
- AbbVie$331K
- plus $965K from 13 others
What the payments were for
- Consulting fees$255,14299%
- Food & beverage$1,5091%
- Education$2340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 23 | $249,417 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $4,212 |
| Biogen | 1 | $1,580 |
| AbbVie(2 entities) | 24 | $495 |
| Sunovion Pharmaceuticals Inc. | 27 | $274 |
| Otsuka America Pharmaceutical, Inc. | 10 | $162 |
| Lundbeck LLC | 10 | $157 |
| Livanova USA, Inc. | 1 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $91 |
| Tris Pharma Inc | 3 | $67 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $62 |
| Shire North American Group Inc | 3 | $43 |
| Avanir Pharmaceuticals, Inc. | 3 | $41 |
| Jazz Pharmaceuticals Inc. | 3 | $40 |
| Bausch Health US, LLC | 2 | $26 |
| Kestra Medical Technology Services, Inc. | 1 | $26 |
| Ironshore Pharmaceuticals Inc. | 2 | $24 |
| Alkermes, Inc. | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $14 |
| Corium, LLC | 1 | $14 |
| Vanda Pharmaceuticals Inc. | 1 | $12 |
| Orexo US, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUNOSI$108,001
- VNS Therapy Symmetry Model 8103 Generator$101
How this compares
$256,884 in reported general payments places this provider in the 95th percentile of 1,119 psychiatry providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 29 | $3,829 |
| Lisdexamfetamine Dimesylate | 12 | $2,399 |
| Fluphenazine Hcl | 13 | $2,153 |
| Methylphenidate ErMethylphenidate Hcl | 13 | $1,732 |
| Buprenorphine Hcl | 31 | $1,025 |
| Atomoxetine Hcl | 12 | $934 |
| Benztropine Mesylate | 32 | $903 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 38 | $865 |
| AmantadineAmantadine Hcl | 13 | $756 |
| Lamotrigine | 28 | $698 |
| Armodafinil | 12 | $660 |
| Dexmethylphenidate Hcl ErDexmethylphenidate Hcl | 13 | $643 |
| Aripiprazole | 33 | $635 |
| Quetiapine Fumarate | 46 | $410 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 24 | $372 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Cherry Hill
- Justin FadenCherry Hill$32K
- Lex DenysenkoCherry Hill$10K
- Marc CantillonLivingston$522K
- Robert BransfieldRed Bank$415K
- Erika ConcepcionLong Branch$354K
- Lloyd AlceraMarlton$187K
- Gary SmallHackensack$170K
- Shankar SrinivasanParsippany$155K
- Matthew PiteraToms River$153K
- Boris BorodulinEast Brunswick$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.